Quantbot Technologies LP Buys 23,443 Shares of Guardian Pharmacy Services, Inc. $GRDN

Quantbot Technologies LP boosted its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 233.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,486 shares of the company’s stock after purchasing an additional 23,443 shares during the quarter. Quantbot Technologies LP owned about 0.05% of Guardian Pharmacy Services worth $878,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GRDN. State of Alaska Department of Revenue purchased a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $30,000. Ameritas Investment Partners Inc. grew its position in shares of Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after buying an additional 345 shares during the last quarter. Parkside Financial Bank & Trust purchased a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth approximately $41,000. Raymond James Financial Inc. bought a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth approximately $43,000. Finally, Police & Firemen s Retirement System of New Jersey raised its stake in shares of Guardian Pharmacy Services by 76.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after acquiring an additional 1,062 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on GRDN. Stephens lifted their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 17th. Finally, Truist Financial boosted their target price on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research note on Friday, November 14th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and an average price target of $32.00.

Guardian Pharmacy Services Stock Down 6.1%

Guardian Pharmacy Services stock opened at $31.88 on Friday. The stock has a 50-day moving average price of $31.63 and a 200 day moving average price of $29.14. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of 50.60 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a 52 week low of $17.78 and a 52 week high of $37.43.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.